Cargando…
Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
Autores principales: | Sookaromdee, Pathum, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701470/ https://www.ncbi.nlm.nih.gov/pubmed/35998273 http://dx.doi.org/10.1002/hep4.2071 |
Ejemplares similares
-
Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023) -
Heterologous COVID-19 vaccination in pregnant women: Comment
por: Sookaromdee, Pathum, et al.
Publicado: (2023) -
Heterologous adenovirus‐vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022) -
Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)